Tokyo Tape
Sign in
← CellSeed

Annual report

7776.TEDINET S100QIL1
Period2022-01-01 → 2022-12-31
Filed2023-03-31
StandardJapan GAAP
ConsolidatedNo
Data checks9 of 12 passed
Key figures · 110
MetricValuePeriodScopeSource row
Revenue¥126m2022-01-01 → 2022-12-31StandaloneNet sales
Revenue¥162m2021-01-01 → 2021-12-31StandaloneNet sales
Revenue¥199m2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Revenue¥276m2019-01-01 → 2019-12-31dStandaloneNet sales (5-year summary)
Revenue¥1.0bn2018-01-01 → 2018-12-31dStandaloneNet sales (5-year summary)
Operating income−¥743m2022-01-01 → 2022-12-31StandaloneOperating income
Operating income−¥864m2021-01-01 → 2021-12-31StandaloneOperating income
Ordinary income−¥754m2022-01-01 → 2022-12-31StandaloneOrdinary income
Ordinary income−¥866m2021-01-01 → 2021-12-31StandaloneOrdinary income
Ordinary income−¥887m2021-01-01 → 2021-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥745m2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥729m2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥786m2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income−¥787m2019-01-01 → 2019-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥141m2018-01-01 → 2018-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥141m2018-01-01 → 2018-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax−¥759m2022-01-01 → 2022-12-31StandaloneIncome before income taxes
Profit before tax−¥909m2021-01-01 → 2021-12-31StandaloneIncome before income taxes
Net income (owners)−¥915m2021-01-01 → 2021-12-31StandaloneProfit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥784m2020-01-01 → 2020-12-31dStandaloneProfit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥782m2019-01-01 → 2019-12-31dStandaloneProfit loss attributable to owners of parent (5-year summary)
Net income (owners)¥130m2018-01-01 → 2018-12-31dStandaloneProfit loss attributable to owners of parent (5-year summary)
Net income−¥760m2022-01-01 → 2022-12-31StandaloneProfit loss
Net income−¥913m2021-01-01 → 2021-12-31StandaloneProfit loss
Net income−¥768m2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Net income−¥783m2019-01-01 → 2019-12-31dStandaloneNet income loss (5-year summary)
Net income¥130m2018-01-01 → 2018-12-31dStandaloneNet income loss (5-year summary)
Total assets¥1.5bnat 2022-12-31StandaloneAssets
Total assets¥1.4bnat 2021-12-31StandaloneAssets
Total assets¥1.4bnat 2021-12-31StandaloneTotal assets (5-year summary)
Total assets¥1.8bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.8bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.5bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.5bnat 2019-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.6bnat 2018-12-31dStandaloneTotal assets (5-year summary)
Total assets¥1.6bnat 2018-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥366mat 2022-12-31StandaloneLiabilities
Total liabilities¥364mat 2021-12-31StandaloneLiabilities
Net assets / equity¥1.2bnat 2022-12-31StandaloneNet assets
Net assets / equity¥1.0bnat 2021-12-31StandaloneNet assets
Net assets / equity¥1.0bnat 2021-12-31StandaloneNet assets (5-year summary)
Net assets / equity¥1.6bnat 2020-12-31dStandaloneNet assets
Net assets / equity¥1.5bnat 2020-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.3bnat 2019-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.4bnat 2019-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.4bnat 2018-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥1.4bnat 2018-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2022-12-31StandaloneCash and deposits
Cash and deposits¥847mat 2021-12-31StandaloneCash and deposits
Cash & equivalents¥1.1bnat 2022-12-31StandaloneCash and cash equivalents
Cash & equivalents¥847mat 2021-12-31StandaloneCash and cash equivalents
Cash & equivalents¥931mat 2021-12-31StandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.5bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.1bnat 2019-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥1.1bnat 2018-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow−¥718m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in operating activities
Operating cash flow−¥817m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥701m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥578m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥307m2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow¥62m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥110m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥13m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥133m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1m2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥882m2022-01-01 → 2022-12-31StandaloneNet cash provided by used in financing activities
Financing cash flow¥397m2021-01-01 → 2021-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.1bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥721m2019-01-01 → 2019-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥25m2018-01-01 → 2018-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥-36.312022-01-01 → 2022-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-53.182021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-53.082021-01-01 → 2021-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-55.312020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-54.192020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-66.62019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-66.682019-01-01 → 2019-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥11.352018-01-01 → 2018-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥11.382018-01-01 → 2018-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥11.272018-01-01 → 2018-12-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥11.32018-01-01 → 2018-12-31dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥47.26at 2022-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥56.44at 2021-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥57.43at 2021-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥93.85at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥95.7at 2020-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥102.24at 2019-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥103.88at 2019-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥121.19at 2018-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥122.78at 2018-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio74.8%at 2022-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio72.0%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio72.4%at 2021-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio83.2%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio83.5%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio91.1%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio91.3%at 2019-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio87.5%at 2018-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio87.3%at 2018-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE9.8%2018-01-01 → 2018-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued24,422,619at 2022-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued17,759,419at 2021-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued16,008,319at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued12,981,819at 2019-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued11,459,419at 2018-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees30at 2022-12-31StandaloneNumber of employees
Employees44at 2021-12-31StandaloneNumber of employees
Employees40at 2020-12-31dStandaloneNumber of employees
Employees40at 2019-12-31dStandaloneNumber of employees
Employees39at 2018-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 21
SegmentItemPeriodValue
Reconciling Itemsreconcilingcapex2022-01-01 → 2022-12-31¥3m
Reconciling Itemsreconcilingsegment assetsat 2022-12-31¥1.3bn
Reconciling Itemsreconcilingsegment profit2022-01-01 → 2022-12-31−¥190m
Cell Sheet Regenerative Medicinereportable segmentemployeesat 2022-12-3119 pure
Cell Sheet Regenerative Medicinereportable segmentrevenue2022-01-01 → 2022-12-31¥10m
Cell Sheet Regenerative Medicinereportable segmentrevenue external2022-01-01 → 2022-12-31¥10m
Cell Sheet Regenerative Medicinereportable segmentsegment assetsat 2022-12-31¥82m
Cell Sheet Regenerative Medicinereportable segmentsegment profit2022-01-01 → 2022-12-31−¥463m
Laboratory Consumables And Equipmentreportable segmentcapex2022-01-01 → 2022-12-31¥563,000
Laboratory Consumables And Equipmentreportable segmentdepreciation2022-01-01 → 2022-12-31¥8m
Laboratory Consumables And Equipmentreportable segmentemployeesat 2022-12-317 pure
Laboratory Consumables And Equipmentreportable segmentrevenue2022-01-01 → 2022-12-31¥116m
Laboratory Consumables And Equipmentreportable segmentrevenue external2022-01-01 → 2022-12-31¥116m
Laboratory Consumables And Equipmentreportable segmentsegment assetsat 2022-12-31¥196m
Laboratory Consumables And Equipmentreportable segmentsegment profit2022-01-01 → 2022-12-31−¥90m
—segment totalcapex2022-01-01 → 2022-12-31¥563,000
—segment totaldepreciation2022-01-01 → 2022-12-31¥8m
—segment totalrevenue2022-01-01 → 2022-12-31¥126m
—segment totalrevenue external2022-01-01 → 2022-12-31¥126m
—segment totalsegment assetsat 2022-12-31¥277m
—segment totalsegment profit2022-01-01 → 2022-12-31−¥553m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 895
ItemContextValueUnit
Total number of shares held treasury shares etcCurrentYearInstant100
Shareholding ratio treasury shares etcCurrentYearInstant0.0000
Number of male directors and other officersFilingDateInstant2
Number of female directors and other officersFilingDateInstant2
Ratio of female directors and other officersFilingDateInstant0.500
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24158-000HashimotoSetsukoMember32700
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24158-000YamaguchiToshioMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24158-000OedaKenjiMember3800
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant_jpcrp030000-asr_E24158-000YukikoEndoMember－
Number of shares held ordinary shares information about directors and corporate auditorsFilingDateInstant36500
Audit fees reporting companyPrior1YearDuration13800000JPY
Non audit fees reporting companyPrior1YearDuration－JPY
Audit fees consolidated subsidiariesPrior1YearDuration－JPY
Non audit fees consolidated subsidiariesPrior1YearDuration－JPY
Audit fees totalPrior1YearDuration13800000JPY
Non audit fees totalPrior1YearDuration－JPY
Audit fees reporting companyCurrentYearDuration12000000JPY
Non audit fees reporting companyCurrentYearDuration－JPY
Total amount of remuneration etc remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember29797000JPY
Fixed remuneration remuneration by category of directors and other officersCurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember29797000JPY
Performance based remuneration remuneration by category of directors and other officersCurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember－JPY
Retirement benefits remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember－JPY
Non monetary remuneration remuneration by category of directors and other officersCurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember－JPY
Number of directors and other officers remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsExcludingAuditAndSupervisoryCommitteeMembersAndOutsideDirectorsMember2
Total amount of remuneration etc remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember－JPY
Fixed remuneration remuneration by category of directors and other officersCurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember－JPY
Performance based remuneration remuneration by category of directors and other officersCurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember－JPY
Retirement benefits remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember－JPY
Non monetary remuneration remuneration by category of directors and other officersCurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember－JPY
Number of directors and other officers remuneration etc by category of directors and other officersCurrentYearDuration_DirectorsAppointedAsAuditAndSupervisoryCommitteeMembersExcludingOutsideDirectorsMember－
Total amount of remuneration etc remuneration etc by category of directors and other officersCurrentYearDuration_OutsideDirectorsAndOtherOfficersMember10160000JPY
Fixed remuneration remuneration by category of directors and other officersCurrentYearDuration_OutsideDirectorsAndOtherOfficersMember10160000JPY
Performance based remuneration remuneration by category of directors and other officersCurrentYearDuration_OutsideDirectorsAndOtherOfficersMember－JPY
Retirement benefits remuneration etc by category of directors and other officersCurrentYearDuration_OutsideDirectorsAndOtherOfficersMember－JPY
Non monetary remuneration remuneration by category of directors and other officersCurrentYearDuration_OutsideDirectorsAndOtherOfficersMember－JPY
Number of directors and other officers remuneration etc by category of directors and other officersCurrentYearDuration_OutsideDirectorsAndOtherOfficersMember4
Cash and depositsPrior1YearInstant_NonConsolidatedMember846674000JPY
Cash and depositsCurrentYearInstant_NonConsolidatedMember1072210000JPY
Accounts receivable tradePrior1YearInstant_NonConsolidatedMember28164000JPY
Accounts receivable tradeCurrentYearInstant_NonConsolidatedMember25775000JPY
Merchandise and finished goodsPrior1YearInstant_NonConsolidatedMember24315000JPY
Merchandise and finished goodsCurrentYearInstant_NonConsolidatedMember19757000JPY
Work in processPrior1YearInstant_NonConsolidatedMember763000JPY
Work in processCurrentYearInstant_NonConsolidatedMember836000JPY
Raw materials and suppliesPrior1YearInstant_NonConsolidatedMember16459000JPY
Raw materials and suppliesCurrentYearInstant_NonConsolidatedMember35573000JPY
Prepaid expensesPrior1YearInstant_NonConsolidatedMember23892000JPY
Prepaid expensesCurrentYearInstant_NonConsolidatedMember21550000JPY
Consumption taxes receivablePrior1YearInstant_NonConsolidatedMember62867000JPY
Consumption taxes receivableCurrentYearInstant_NonConsolidatedMember45210000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 9 of 12 passed
balance sheet identitynon_consolidated 2021-12-31pass rounding
balance sheet identitynon_consolidated 2022-12-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2020-12-31mismatch
statement vs summary · net assetsnon_consolidated 2021-12-31mismatch
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · operating cash flownon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · revenuenon_consolidated 2021-01-01/2021-12-31pass
statement vs summary · revenuenon_consolidated 2022-01-01/2022-12-31pass
statement vs summary · total assetsnon_consolidated 2021-12-31mismatch
statement vs summary · total assetsnon_consolidated 2022-12-31pass